Skip to Main Content

Disclaimer »
Advertising

Shopping Cart
shopAAP
Shopping Cart
Create Account
Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination
Share
Vials

Risk of pseudotumor cerebri added to labeling for gonadotropin-releasing hormone agonists

July 1, 2022
from the Food and Drug Administration
Article type: FDA Update
Topics:
Endocrinology Hematology/Oncology Nephrology Therapeutics Urology
You do not currently have access to this content.
Don't already have an account? Register

Advertising Disclaimer »

Most Read

1. Colleagues mourn loss of Talat J. Khan, pediatrician killed in Texas

2. Study: Adolescent school shooters often use guns stolen from family

3. Neonatal resuscitation guideline updates endorsed by AAP, American Heart Association

December issue digital edition

 

Subscribe to AAP News

Column collections

Topic collections

  • Online ISSN 1556-3332
  • Print ISSN 1073-0397

Journals

Policy

Books

News

Solutions

First 1,000 Days Knowledge Center


Institutions/Librarians

Group Practices

Licensing/Permissions

Integrations

Advertising

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept